FDA Approves New Asparaginase Product for Leukemia ...Middle East

Medscape - News
The new recombinant product, Rylaze, is approved for use in patients who have developed hypersensitivity to asparaginase derived from E coli. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves New Asparaginase Product for Leukemia )

Apple Storegoogle play

Also on site :



Latest News